Icon Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.17M Sell
8,424
-5,936
-41% -$6.02M 0.47% 44
2025
Q4
$15.3M Sell
14,360
-203
-1% -$194K 1.02% 26
2025
Q3
$11.1M Buy
14,563
+430
+3% +$320K 0.75% 33
2025
Q2
$11M Sell
14,133
-69
-0.5% -$53.6K 0.78% 30
2025
Q1
$11.7M Buy
14,202
+2,165
+18% +$1.8M 0.96% 24
2024
Q4
$9.29M Buy
12,037
+2,436
+25% +$2.02M 0.76% 27
2024
Q3
$8.51M Sell
9,601
-126
-1% -$113K 0.71% 27
2024
Q2
$7.82M Buy
9,727
+477
+5% +$382K 0.7% 27
2024
Q1
$7.2M Buy
9,250
+24
+0.3% +$17.1K 0.67% 28
2023
Q4
$5.38M Buy
+9,226
New +$5.39M 0.56% 33
2022
Q4
$5.22M Buy
14,270
+37
+0.3% +$13.1K 0.6% 43
2022
Q3
$4.6M Buy
+14,233
New +$4.51M 0.56% 41

Other funds holding LLY

Icon Wealth Advisors's LLY Position: Q1 2026 in Review

Icon Wealth Advisors reduced its Eli Lilly (LLY) stake by 41% in Q1 2026, selling an estimated $6.02M and leaving 8,424 shares worth $7.17M. The position accounts for 0.47% of the portfolio, ranked #44.

Icon Wealth Advisors first reported a position in LLY in Q3 2022 and has held it in 12 quarters since. The position peaked at $15.3M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Icon Wealth Advisors held 8,424 shares of Eli Lilly worth $7.17M as of Q1 2026.
  • Icon Wealth Advisors sold 5,936 Eli Lilly shares in Q1 2026, an estimated $6.02M.
  • Eli Lilly made up 0.47% of Icon Wealth Advisors's portfolio in Q1 2026, its #44 holding.
  • Icon Wealth Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 12 quarters since.
  • Icon Wealth Advisors's Eli Lilly position peaked at $15.3M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Icon Wealth Advisors's 13F filing for Q1 2026, filed 12 May 2026.